Accelerating the introduction of rotavirus immunization in Indonesia
- PMID: 24580504
- DOI: 10.1586/14760584.2014.891940
Accelerating the introduction of rotavirus immunization in Indonesia
Abstract
The introduction of the rotavirus vaccine in Indonesia is currently in its infancy. Delay in its development might be caused by factors related to the perceived value of the vaccine, health system characteristics and policy considerations. Other factors, which may also interfere with optimizing the introduction, are financial barriers because Indonesia is a lower-middle-income country. Creating fiscal space to finance new immunization programs, such as for the rotavirus immunization, is very important to ensure the sustainability of new programs so that such programs would be financed over the long term and not endanger the sustainability of the Indonesian government's financial position. This article provides an illustration of the various steps needed to accelerate the introduction of the rotavirus immunization.
Similar articles
-
Rotavirus vaccines: targeting the developing world.J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6. doi: 10.1086/431504. J Infect Dis. 2005. PMID: 16088799
-
Rotavirus vaccines in Belgium: policy and impact.Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S21-4. doi: 10.1097/INF.0b013e3181fefc51. Pediatr Infect Dis J. 2011. PMID: 21183836
-
Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.Arch Virol. 2008;153(3):591-3. doi: 10.1007/s00705-007-0028-z. Epub 2008 Jan 4. Arch Virol. 2008. PMID: 18175037
-
Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.Expert Rev Vaccines. 2014 Jan;13(1):43-57. doi: 10.1586/14760584.2014.861746. Epub 2013 Dec 4. Expert Rev Vaccines. 2014. PMID: 24308577 Review.
-
Rotavirus vaccination within the South African Expanded Programme on Immunisation.Vaccine. 2012 Sep 7;30 Suppl 3:C14-20. doi: 10.1016/j.vaccine.2012.04.018. Vaccine. 2012. PMID: 22939015 Review.
Cited by
-
Cost-effectiveness and budget impact analyses of dengue vaccination in Indonesia.PLoS Negl Trop Dis. 2021 Aug 12;15(8):e0009664. doi: 10.1371/journal.pntd.0009664. eCollection 2021 Aug. PLoS Negl Trop Dis. 2021. PMID: 34383764 Free PMC article.
-
Cost-Effectiveness of Dengue Vaccination in Indonesia: Considering Integrated Programs with Wolbachia-Infected Mosquitos and Health Education.Int J Environ Res Public Health. 2020 Jun 12;17(12):4217. doi: 10.3390/ijerph17124217. Int J Environ Res Public Health. 2020. PMID: 32545688 Free PMC article.
-
Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia.J Environ Public Health. 2021 Apr 27;2021:7494965. doi: 10.1155/2021/7494965. eCollection 2021. J Environ Public Health. 2021. PMID: 33995536 Free PMC article.
-
The Effect of E-Learning on the Attitude Toward Dengue Prevention and the Acceptance of Dengue Vaccination.Patient Prefer Adherence. 2021 Apr 15;15:785-792. doi: 10.2147/PPA.S296758. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 33883886 Free PMC article.
-
Cost-Effectiveness of Ferrous Fumarate-Folic Acid and Ferrous Gluconate-Multivitamins in a High Prevalence Area of Iron Deficiency Anemia in Indonesia.Ther Clin Risk Manag. 2021 Oct 1;17:1075-1081. doi: 10.2147/TCRM.S328226. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 34629872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical